Cell and gene therapy for personalised medicine
Celle- og genterapi for persontilpasset medisin
- Closes
- 20 Jan 2027
- 66 days left
- Funding per project
- up to 1 600 000 EUR
- Who can apply
- SMEs, Large companies, Research organisations, Public bodies, Consortia
- Open to applicants from
- Norway
What this call funds
Cross-disciplinary, cross-sector research consortia can apply to develop and validate innovative new cell or gene therapies for personalised medicine, using somatic cell therapy, gene therapy, combined cell and gene therapy, or new biological products such as mRNA or extracellular vesicles. The Research Council of Norway contributes up to EUR 1.6 million per applicant, and companies such as SMEs can receive up to 50% of eligible project costs under state aid rules. The pre-proposal deadline is 20 January 2027 and the full application deadline is 25 May 2027.
The call in detail
- Funder
- Research Council of Norway
- Programme
- European Partnership for Personalised Medicine (EP PerMed)
- Type
- Grant
- Funding per project
- up to 1 600 000 EUR
- Total budget of the call
- 38 000 000 EUR
- Funding rate
- Up to 50% of eligible costs
- Eligible applicants
- SMEs, Large companies, Research organisations, Public bodies, Consortia
- Eligible countries
- Norway
- Startup relevance
- Medium
- Source
- Forskningsrådet — calls for industry (Næringsliv)
Key dates
- 20 Jan 2027
- Applications close
- 25 May 2027
- Cut-off date
Earlier rounds and changes
| Recorded | What changed | Details |
|---|---|---|
| 14 Nov 2026 | First listed here | Already listed when the source was first read |
Similar open calls
Open calls like this one are listed for free accounts. Start with a free account to see them, save searches and get an e-mail when a new call matches.
Create free accountSummaries and extracted fields are generated automatically from the official page and may contain mistakes. Check the official page before applying.